Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Integrated Epigenetic Profiling Identifies EZH2 As a Therapeutic Target to Re-Establish Immune Recognition of Leukemia Relapses with Loss of HLA Class II Expression

Valentina Gambacorta, MSc, Daniela Gnani, PhD, Laura Zito, MSc, Stefano Beretta, PhD, Lucia Zanotti, PhD, Oliveira Giacomo, PhD, Davide Cittaro, PhD, Ivan Merelli, PhD, Fabio Ciceri, MD, Raffaella Di Micco, PhD, Luca Vago, MD PhD

Blood (2019) 134 (Supplement_1): 514.

https://doi.org/10.1182/blood-2019-127395

Published: 2019

Journal Articles

Microrna-126 Levels Modulate B-ALL Aggressiveness but Require Tight Regulation to Guarantee Disease Maintenance

Carolina Caserta, Silvia Nucera, MD, Matteo Maria Naldini, Nadia Foligno, Giacomo Desantis, PhD, Fabio Ciceri, MD, Davide Cittaro, PhD, Bernhard Gentner, MD

Blood (2018) 132 (Supplement 1): 2834.

https://doi.org/10.1182/blood-2018-99-115101

Published: 2018

Journal Articles

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Lucia Zanotti, PhD, Gabriele Bucci, PhD, Francesco Santaniello, Cristina Toffalori, Donatella Biancolini, PhD, Ettore Zapparoli, Laura Zito, Matteo Giovanni Carrabba, MD, Friedrich Stoelzel, Martin Bornhäuser, Massimo Bernardi, MD, Jacopo Peccatori, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, Giovanni Tonon, MD PhD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2018) 132 (Supplement 1): 819.

https://doi.org/10.1182/blood-2018-99-111769

Published: 2018

Journal Articles

Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation

Cristina Toffalori, PhD, Michela Riba, PhD, Laura Zito, BSc, Matteo Barcella, MSc, Orietta Spinelli, PhD, Lara Crucitti, MD, Nicoletta Cieri, MD PhD, Jacopo Peccatori, MD, Massimo Bernardi, MD, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Alessandro Rambaldi, Cristina Barlassina, BSc, Elia Stupka, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Luca Vago, MD PhD

Blood (2014) 124 (21): 427.

https://doi.org/10.1182/blood.V124.21.427.427

Published: 2014

Journal Articles

Backtracking Leukemia Clonal Evolution from Post-Transplantation Relapse to Initial Diagnosis to Identify Founder Mutations and Mechanisms of Immune Evasion

Blood (2014) 124 (21): 1185.

https://doi.org/10.1182/blood.V124.21.1185.1185

Published: 2014

Journal Articles

Identification By Gene Expression Profiling Of CIITA-Dependent HLA Class II Transcriptional Downregulation As a Novel Mechanism Of Leukemia Immune Escape and Relapse After Allogeneic HSCT

Cristina Toffalori, PhD, Michela Riba, PhD, Matteo Barcella, MSc, Orietta Spinelli, PhD, Lara Crucitti, MD, Jacopo Peccatori, MD, Massimo Bernardi, MD, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Alessandro Rambaldi, MD, Cristina Barlassina, BSc, Elia Stupka, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Luca Vago, MD, PhD

Blood (2013) 122 (21): 3748.

https://doi.org/10.1182/blood.V122.21.3748.3748

Published: 2013

Journal Articles

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Luca Vago, MD, PhD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Cristina Toffalori, PhD, Giacomo Oliveira, MSc, Lorenza Chiesa, BSc, Benedetta Mazzi, BSc, Maurilio Ponzoni, MD, Matteo Carrabba, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Katharina Fleischhauer, MD, Fabio Ciceri, MD, Elia Stupka, PhD

Blood (2013) 122 (21): 1369.

https://doi.org/10.1182/blood.V122.21.1369.1369

Published: 2013

NARROW

Integrated Epigenetic Profiling Identifies EZH2 As a Therapeutic Target to Re-Establish Immune Recognition of Leukemia Relapses with Loss of HLA Class II Expression

Microrna-126 Levels Modulate B-ALL Aggressiveness but Require Tight Regulation to Guarantee Disease Maintenance

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation

Backtracking Leukemia Clonal Evolution from Post-Transplantation Relapse to Initial Diagnosis to Identify Founder Mutations and Mechanisms of Immune Evasion

Identification By Gene Expression Profiling Of CIITA-Dependent HLA Class II Transcriptional Downregulation As a Novel Mechanism Of Leukemia Immune Escape and Relapse After Allogeneic HSCT

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Email alerts

ASH Publications

American Society of Hematology

Integrated Epigenetic Profiling Identifies EZH2 As a Therapeutic Target to Re-Establish Immune Recognition of Leukemia Relapses with Loss of HLA Class II Expression

Microrna-126 Levels Modulate B-ALL Aggressiveness but Require Tight Regulation to Guarantee Disease Maintenance

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation

Backtracking Leukemia Clonal Evolution from Post-Transplantation Relapse to Initial Diagnosis to Identify Founder Mutations and Mechanisms of Immune Evasion

Identification By Gene Expression Profiling Of CIITA-Dependent HLA Class II Transcriptional Downregulation As a Novel Mechanism Of Leukemia Immune Escape and Relapse After Allogeneic HSCT

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only